Metformin Aurobindo

Metformin Hydrochloride, the active ingredient in Metformin Aurobindo, is a biguanide presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adult patients by improving blood‑sugar control. GNH USA supplies Metformin Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Aurobindo belongs to the biguanide class and is used to manage disorders of glucose metabolism. - Type 2 diabetes mellitus: lowers fasting and post‑prandial glucose levels to achieve glycaemic targets. - Prediabetes (impaired fasting glucose): delays progression to overt diabetes by improving insulin sensitivity. - Gestational diabetes mellitus (adjunct therapy): assists in controlling maternal blood glucose when diet alone is insufficient.

Metformin Aurobindo may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools, often transient. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening metabolic disturbance. - Severe hypoglycaemia: usually when combined with insulin or sulfonylureas. - Hepatic dysfunction: abnormal liver enzymes or hepatitis. - Allergic reactions: rash, pruritus, or angio‑edema. - Pancreatitis: inflammation of the pancreas. - Skin reactions: severe rash or Stevens‑Johnson syndrome.

Metformin Aurobindo requires careful monitoring and patient education to minimise risks. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic function: evaluate liver enzymes in patients with known liver disease. - Risk of lactic acidosis: avoid in patients with hypoxia, severe heart failure, or uncontrolled infection. - Concomitant drugs: review medications that may impair renal clearance or increase metformin exposure. - Elderly patients: start at lower dose and titrate cautiously. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metformin Aurobindo can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Alcohol: increases risk of lactic acidosis. - Iodinated contrast agents: may precipitate acute kidney injury, requiring temporary discontinuation. - Cimetidine: can raise metformin plasma concentrations. - Rifampicin: may reduce metformin exposure. - Nitrates: concurrent use can cause hypotension.

Moderate Interactions (Monitor Closely): - Sulfonylureas: heightened risk of hypoglycaemia. - Beta‑blockers: may mask hypoglycaemic symptoms. - Diuretics: can affect renal function and metformin clearance. - ACE inhibitors/ARBs: monitor renal function and electrolytes. - NSAIDs: may impair renal perfusion, increasing metformin levels.